These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15213574)

  • 1. Polyunsaturated ethyl esters of n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy.
    Manfredi R; Calza L; Chiodo F
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):878-80. PubMed ID: 15213574
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.
    Peters BS; Wierzbicki AS; Moyle G; Nair D; Brockmeyer N
    Clin Ther; 2012 Jan; 34(1):67-76. PubMed ID: 22212377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial of omega-3 fatty acid supplementation for the treatment of hypertriglyceridemia in HIV-infected males on highly active antiretroviral therapy.
    Carter VM; Woolley I; Jolley D; Nyulasi I; Mijch A; Dart A
    Sex Health; 2006 Dec; 3(4):287-90. PubMed ID: 17112442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids and hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: systematic review and meta-analysis.
    Oliveira JM; Rondó PH
    HIV Clin Trials; 2011; 12(5):268-74. PubMed ID: 22180524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of omega-3 fatty acids on the lipid structure of HIV-positive patients on antiretroviral therapy: personal observation of 20 subjects].
    Ranieri R
    Infez Med; 2007 Dec; 15(4):237-41. PubMed ID: 18162734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of fenofibrate for the treatment of hypertriglyceridemia associated with antiretroviral therapy.
    Palacios R; Santos J; González M; Ruiz J; Valdivielso P; Márquez M; González-Santos P
    J Acquir Immune Defic Syndr; 2002 Oct; 31(2):251-3. PubMed ID: 12394806
    [No Abstract]   [Full Text] [Related]  

  • 7. Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids.
    Brunton S; Collins N
    Curr Med Res Opin; 2007 May; 23(5):1139-45. PubMed ID: 17519081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians.
    Bays H
    Drugs Today (Barc); 2008 Mar; 44(3):205-46. PubMed ID: 18536782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for severe hypertriglyceridemia treatment, are there new strategies?
    Filippatos TD; Elisaf MS
    Curr Vasc Pharmacol; 2014; 12(4):598-616. PubMed ID: 23627980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids enhance monocyte-suppressing effect of bezafibrate in patients with isolated hypertriglyceridemia.
    Krysiak R; Gdula-Dymek A; Okopien B
    Eur J Intern Med; 2012 Oct; 23(7):e171-2. PubMed ID: 22854277
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of hypertriglyceridaemia caused by combination antiretroviral therapy in HIV-infected patients: role of omega-3 polyunsaturated fatty acids at different dosages, compared with fibrates.
    Manfredi R
    Int J STD AIDS; 2010 Jan; 21(1):73-4. PubMed ID: 19843616
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary. Secondary causes of hypertriglyceridemia and pancreatitis.
    Wagh A; Stone NJ
    Clin Chim Acta; 2003 Jun; 332(1-2):21. PubMed ID: 12763275
    [No Abstract]   [Full Text] [Related]  

  • 13. Using omega-3 fatty acids in the practice of clinical lipidology.
    Brown WV; Bays H; Harris W; Miller M
    J Clin Lipidol; 2011; 5(6):424-33. PubMed ID: 22108145
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte-suppressing effects of omega-3 fatty acids in bezafibrate-treated patients with isolated hypertriglyceridemia.
    Krysiak R; Gdula-Dymek A; Okopien B
    Eur J Intern Med; 2012 Sep; 23(6):e166-7. PubMed ID: 22863445
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment: fish oil to keep the cardiologist away?
    Wohl DA
    AIDS Read; 2007 Jul; 17(7):371. PubMed ID: 17672016
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of n-3 fatty acids in the treatment of hypertriglyceridemia in HIV/AIDS patients: a meta-analysis.
    Vieira ADS; Silveira GRMD
    Cien Saude Colet; 2017 Aug; 22(8):2659-2669. PubMed ID: 28793080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
    Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
    Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which dose of omega-3 fatty acids must be taken in different cases of hypertriglyceridemia?
    Mogoş T; Dondoi C
    Rom J Intern Med; 2008; 46(1):81-6. PubMed ID: 19157275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.
    Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495
    [No Abstract]   [Full Text] [Related]  

  • 20. Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia.
    Tatsuno I
    Expert Rev Cardiovasc Ther; 2014 Nov; 12(11):1261-8. PubMed ID: 25319059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.